Launch week offerEnds in00h00m00s

annual Promonthly Pro

Francesca Vinchi

Associate Professor

Emory University

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (9)

Antonella Nai

Group Leader

Ospedale San Raffaele

ITALY

View details

Yelena Ginzburg

PI - Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

Martina Muckenthaler

Prof. Dr. phil. nat

University Medical Center

GERMANY

View details

PAOLA CICERI

Assistant Professor

University of Milan

ITALY

View details

Patrick Mark

Professor of Nephrology

University of Glasgow

UNITED KINGDOM

View details

Antonello Pietrangelo

Docenti di ruolo di Ia fascia

University of Modena and Reggio Emilia

ITALY

View details

Jose Manuel Fernández-Real

Adjunt Professor

Universitat de Girona

SPAIN

View details

Mario Cozzolino

University of Milan

ITALY

View details

Laura Silvestri

Project Leader-Senior Scientist

Ospedale San Raffaele

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Francesca Vinchi

Research Interests

Make your next move.

Explore related searches

Articles (20)

Iron Overload

Therapeutic Phlebotomy

Macrophages in Hematopoiesis and Related Blood Diseases

Genetic iron overload aggravates, and pharmacological iron restriction improves, MDS pathophysiology in a preclinical study

Current Landscape of Hepcidin Therapeutics

Iron biology

Author Correction: Consensus Statement on the definition and classification of metabolic hyperferritinaemia

Improving CORM technology for the treatment of delayed hemolytic transfusion reaction

Heme- and iron-activated macrophages in sickle cell disease: an updated perspective

Hemolysis-driven IFNα production impairs erythropoiesis by negatively regulating EPO signaling in sickle cell disease

Luspatercept: A peaceful revolution in the standard of care for myelodysplastic neoplasms

New partners for Luspatercept in β-thalassemia

News on sickle cell disease: Heme-driven disordered erythropoiesis

Novel frontiers in gene therapy: In vivo gene editing

Targeting bone marrow mechanosensation in myelofibrosis

Consensus Statement on the definition and classification of metabolic hyperferritinaemia

Flavor of Iron at EHA2023: Novel Regulatory Mechanisms and Therapeutic Options for the Correction of Anemia

S286: TARGETING CONDITIONING-ELICITED NON-TRANSFERRIN-BOUND IRON BY TMPRSS6 SILENCING IMPROVES BONE MARROW TRANSPLANT OUTCOME

Not All Heme is “Free” in Sickle Cell Disease

Elevated Transferrin at High Altitude: Trick or Treat?

Collaborators (9)

Antonella Nai

Yelena Ginzburg

Martina Muckenthaler

PAOLA CICERI

Patrick Mark

Antonello Pietrangelo

Jose Manuel Fernández-Real

Mario Cozzolino

Laura Silvestri

Make your next move.